Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Journal of Pharmacology

• Publication date

  2015-08-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2015.04.017PMID 25912800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Research progress in signalling pathway in diabetic nephropathy

  2015cited by this paper
• Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-κB/AP-1 pathways.

  2014cited by this paper
• Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis

  2014influential reference
• The renoprotective effects of berberine via the EP4-Gαs-cAMP signaling pathway in different stages of diabetes in rats

  2014influential reference
• Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy

  2014cited by this paper
• [Progress of berberine for treatment of type 2 diabetes].

  2014cited by this paper
• Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.

  2013cited by this paper
• Berberine Ameliorates Chronic Kidney Injury Caused by Atherosclerotic Renovascular Disease through the Suppression of NFκB Signaling Pathway in Rats

  2013cited by this paper
• Berberine Ameliorate Oxidative Stress and Astrogliosis in the Hippocampus of STZ-Induced Diabetic Rats

  2013cited by this paper
• Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway.

  2013cited by this paper
• Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth.

  2013cited by this paper
• Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy

  2013cited by this paper
• Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy

  2012cited by this paper
• Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor Pathway in Experimental Diabetic Nephropathy Models

  2012cited by this paper
• Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin.

  2012cited by this paper
• Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells.

  2012cited by this paper
• Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis

  2011cited by this paper
• Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats

  2011cited by this paper
• Targeting inflammation by modulating the Jun/AP-1 pathway

  2011cited by this paper
• Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.

  2011cited by this paper
• Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy

  2011cited by this paper
• Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway.

  2011cited by this paper
• Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.

  2010cited by this paper
• Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes

  2010cited by this paper
• Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats.

  2009cited by this paper
• Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy

  2009cited by this paper
• Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes

  2009cited by this paper
• Oxidative stress-induced JNK activation contributes to proinflammatory phenotype of aging diabetic mesangial cells.

  2009cited by this paper
• Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose.

  2009cited by this paper
• Berberine suppresses proinflammatory responses through AMPK activation in macrophages.

  2009cited by this paper
• Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy.

  2009cited by this paper
• Targeting of RhoA/ROCK Signaling Ameliorates Progression of Diabetic Nephropathy Independent of Glucose Control

  2008cited by this paper
• Efficacy of berberine in patients with type 2 diabetes mellitus.

  2008cited by this paper
• Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.

  2008cited by this paper
• Role of matrix metalloproteinases in renal pathophysiologies.

  2007cited by this paper
• Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte

  2006cited by this paper
• Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury.

  2006cited by this paper
• Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

  2005cited by this paper
• Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.

  2005cited by this paper
• Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin

  2005cited by this paper
• Interleukin-6 depletion selectively improves hepatic insulin action in obesity.

  2005cited by this paper
• AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.

  2005cited by this paper
• Activation of the Sphingosine Kinase–Signaling Pathway by High Glucose Mediates the Proinflammatory Phenotype of Endothelial Cells

  2005cited by this paper
• NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.

  2004cited by this paper
• New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology

  2004cited by this paper
• Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.

  2004cited by this paper
• Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

  2004influential reference
• Progression of diabetic nephropathy.

  2003cited by this paper
• Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

  2003cited by this paper
• The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation.

  2001cited by this paper
• The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1/2 activation is independent of angiotensin AT(1A) receptor internalisation.

  2001cited by this paper
• Aldose reductase and the role of the polyol pathway in diabetic nephropathy.

  2000cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• Identification of Mrna Binding Proteins That Regulate the Stability of Ldl Receptor Mrna through Au-rich Elements

  year unknowncited by this paper

• A Berberine Derivative for Treatment of Type 2 Diabetes.

  2025cites this paper
• The application of procyanidins in diabetes and its complications: a review of preclinical studies

  2025cites this paper
• Pharmacokinetics of colistin sulfate and berberine sulfate following intramuscular injection as single agents or in combination in swine

  2025cites this paper
• Understanding the Mechanisms of Lipid Metabolism Reprogramming and Ferroptosis in Diabetic Kidney Disease Progression

  2025cites this paper
• Targeting NF-κB in diabetic nephropathy: exploring the therapeutic potential of phytoconstituents

  2025cites this paper
• Compare Phellodendri Chinensis Cortex before and after salt-water processing to ameliorate diabetic nephropathy via metabolomics and microbiome analysis.

  2025cites this paper
• Herbal Treatments for Obesity: A Review.

  2024cites this paper
• From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer

  2024cites this paper
• Insights into the Therapeutic Uses of Plant Derive Phytocompounds on Diabetic Nephropathy.

  2024cites this paper
• Novel approaches and therapeutic targets for diabetic nephropathy: Advances and promising strategies

  2024cites this paper
• Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer’s disease: a systematic review and meta-analysis

  2024cites this paper
• Oxyberberine Protects Middle Cerebral Artery Occlusion Triggered Cerebral Injury Through TLR4/NLRP3 Pathway in Rats.

  2024cites this paper
• The Potential of Naturally Derived Compounds for Treating Chronic Kidney Disease: A Review of Autophagy and Cellular Senescence

  2024cites this paper
• Cardiovascular Effects of Herbal Products and Their Interaction with Antihypertensive Drugs—Comprehensive Review

  2024cites this paper
• Application of Traditional Chinese Medicine in Inhibiting the PD-1/PD-L1 Pathway in the Treatment of Gastric and Colon Cancers

  2024cites this paper
• Protective Effects of Bioactive Compound-Derived Nanoparticle Against Diabetic Retinopathy Through the Modulation of the NF-κB Signaling Pathway

  2024cites this paper
• Potential role of resveratrol in prevention and therapy of diabetic complications: a critical review

  2024cites this paper
• Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy

  2023cites this paper
• Modified Hu-lu-ba-wan protects diabetic glomerular podocytes via promoting PKM2-mediated mitochondrial dynamic homeostasis.

  2023cites this paper
• Comparative pharmacokinetic analysis of six major bioactive constituents using UPLC-MS/MS in samples isolated from normal and diabetic nephropathy rats after oral administration of Gushen Jiedu capsule.

  2023cites this paper
• Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease

  2023cites this paper
• Simultaneous Administration of Berberine and Transplantation of Endometrial Stem Cell-Derived Insulin Precursor Cells on a Nanofibrous Scaffold to Treat Diabetes Mellitus in Mice

  2023cites this paper
• Pd‐Catalyzed Regioselective Domino C‐C Bond Formation to Access N‐Fused Benzimidazo‐Indolo‐Isoquinoline Heterocycles

  2023cites this paper
• Treatment of berberine alleviates diabetic nephropathy by reducing iron overload and inhibiting oxidative stress.

  2023cites this paper
• Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention

  2023cites this paper
• Gut microbiota intervention strategies using active components from medicinal herbs to evaluate clinical efficacy of type 2 diabetes – A review

  2023cites this paper
• Berberine Alleviates the Damage, Oxidative Stress and Mitochondrial Dysfunction of PC12 Cells Induced by High Glucose by Activating the KEAP1/Nrf2/ARE Pathway

  2023cites this paper
• Role of SIRT-1 as a target for treatment and prevention of Diabetic Nephropathy: A Review.

  2023cites this paper
• Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway

  2022cites this paper
• Thermally Treated Berberine-Loaded SA/PVA/PEO Electrospun Microfiber Membranes for Antibacterial Wound Dressings

  2022cites this paper
• Berberine Reduces Lipid Accumulation by Promoting Fatty Acid Oxidation in Renal Tubular Epithelial Cells of the Diabetic Kidney

  2022cites this paper
• Traditional Chinese medicine compounds ameliorating glomerular diseases via autophagy: A mechanism review.

  2022cites this paper
• An insight into the potential of berberine in animal nutrition: Current knowledge and future perspectives.

  2022cites this paper
• Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease

  2022cites this paper
• Several Alkaloids in Chinese Herbal Medicine Exert Protection in Acute Kidney Injury: Focus on Mechanism and Target Analysis

  2022cites this paper
• Berberine as a Potential Agent for the Treatment of Colorectal Cancer

  2022cites this paper
• Long noncoding RNA X-inactive specific transcript regulates NLR family pyrin domain containing 3/caspase-1-mediated pyroptosis in diabetic nephropathy

  2022cites this paper
• Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs.

  2021cites this paper
• DDDT_A_317776 3241..3254

  2021cites this paper
• Berberine and lycopene as alternative or add-on therapy to metformin and statins, a review.

  2021cites this paper
• Ginsenoside Rg1 attenuates the inflammation and oxidative stress induced by diabetic nephropathy through regulating the PI3K/AKT/FOXO3 pathway

  2021cites this paper
• Berberine Reduces Renal Cell Pyroptosis in Golden Hamsters with Diabetic Nephropathy through the Nrf2-NLRP3-Caspase-1-GSDMD Pathway

  2021cites this paper
• Potential Therapeutic Effects of Natural Plant Compounds in Kidney Disease

  2021cites this paper
• Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model

  2021cites this paper
• Anti-obesity natural products

  2020cites this paper
• Berberine mitigates high glucose-induced podocyte apoptosis by modulating autophagy via the mTOR/P70S6K/4EBP1 pathway.

  2020cites this paper
• A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications.

  2020cites this paper
• A rapid method for simultaneous quantification of berberine, berbamine, magnoflorine and berberrubine in mouse serum using UPLC-MS/MS.

  2020cites this paper
• Comparison Among Garlic, Berberine, Resveratrol, Hibiscus sabdariffa, Genus Zizyphus, Hesperidin, Red Beetroot, Catha edulis, Portulaca oleracea, and Mulberry Leaves in the Treatment of Hypertension and Type 2 DM: A Comprehensive Review

  2020cites this paper
• The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.

  2020cites this paper
• Effect of Berberine on Glycation, Aldose Reductase Activity, and Oxidative Stress in the Lenses of Streptozotocin-Induced Diabetic Rats In Vivo—A Preliminary Study

  2020cites this paper
• Diabetes and plant‐derived natural products: From ethnopharmacological approaches to their potential for modern drug discovery and development

  2020cites this paper
• Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation

  2020cites this paper
• Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5

  2020cites this paper
• Berberine alleviates palmitic acid-induced podocyte apoptosis by reducing reactive oxygen species-mediated endoplasmic reticulum stress

  2020cites this paper
• Activation of Akt‐dependent Nrf2/ARE pathway by restoration of Brg‐1 remits high glucose‐induced oxidative stress and ECM accumulation in podocytes

  2020cites this paper
• Herbal nanotherapy: A new paradigm over conventional obesity treatment

  2020cites this paper
• Effects of Berberine on Development in Caenorhabditis elegans

  2020cites this paper
• Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials.

  2019cites this paper
• Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3‐kinase–protein kinase B pathway in diabetic rats

  2019cites this paper
• Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis.

  2019cites this paper
• Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction

  2019cites this paper
• Berberine, a Traditional Chinese Medicine, Reduces Inflammation in Adipose Tissue, Polarizes M2 Macrophages, and Increases Energy Expenditure in Mice Fed a High-Fat Diet

  2019cites this paper
• Berberine protects against diabetic kidney disease via promoting PGC‐1α‐regulated mitochondrial energy homeostasis

  2019cites this paper
• ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy.

  2019cites this paper
• A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling

  2019cites this paper
• Myocardial hypertrophy is improved with berberine treatment via long non‐coding RNA MIAT‐mediated autophagy

  2019cites this paper
• Berberine (BBR) Attenuated Palmitic Acid (PA)-Induced Lipotoxicity in Human HK-2 Cells by Promoting Peroxisome Proliferator-Activated Receptor a (PPAR-a)

  2019cites this paper
• Neuregulin 4 attenuate tubulointerstitial fibrosis and advanced glycosylation end products accumulation in diabetic nephropathy rats via regulating TNF-R1 signaling.

  2019cites this paper
• Berberine

  2019cites this paper
• Berberine Attenuates Cigarette Smoke Extract-induced Airway Inflammation in Mice: Involvement of TGF-β1/Smads Signaling Pathway

  2019cites this paper
• Renal vectorial transport of berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats

  2018cites this paper
• Chapter 2 Berberine and Its Role in Chronic Disease

  2018cites this paper
• Berberine Protects Against Palmitate-Induced Apoptosis in Tubular Epithelial Cells by Promoting Fatty Acid Oxidation

  2018cites this paper
• Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF‐&kgr;B signaling pathway to protect against DSS‐induced colitis☆

  2018cites this paper
• Taxus chinensis ameliorates diabetic nephropathy through down-regulating TGF-β1/Smad pathway.

  2018cites this paper
• Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77.

  2018cites this paper
• Precise Dissolution Control and Bioavailability Evaluation for Insoluble Drug Berberine via a Polymeric Particle Prepared Using Supercritical CO2

  2018cites this paper
• Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs.

  2018cites this paper
• Protective effects of plant‐derived natural products on renal complications

  2018cites this paper
• Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4/NF-κB/NLRP3 inflammasome pathway.

  2018cites this paper
• The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine

  2018cites this paper
• Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine

  2018cites this paper
• Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms

  2018cites this paper
• What has traditional Chinese medicine delivered for modern medicine?

  2018cites this paper
• Berberine alleviates oxidative stress in islets of diabetic mice by inhibiting miR-106 b expression and up-regulating SIRT 1 † Running title : The application of berberine in diabetes

  2017cites this paper
• Berberine reduced blood pressure and improved vasodilation in diabetic rats.

  2017cites this paper
• Chinese medicine for diabetic kidney disease in China

  2017cites this paper
• Aptamer-functionalized Fe3 O4 magnetic nanoparticles as a solid-phase extraction adsorbent for the selective extraction of berberine from Cortex phellodendri.

  2017cites this paper
• Berberine Alleviates Oxidative Stress in Islets of Diabetic Mice by Inhibiting miR‐106b Expression and Up‐Regulating SIRT1

  2017cites this paper
• Identification of actin as a direct proteomic target of berberine using an affinity-based chemical probe and elucidation of its modulatory role in actin assembly.

  2017cites this paper
• Preparation, pharmacokinetics and tumour‐suppressive activity of berberine liposomes

  2017cites this paper
• Role of the Benzodioxole Group in the Interactions between the Natural Alkaloids Chelerythrine and Coptisine and the Human Telomeric G-Quadruplex DNA. A Multiapproach Investigation.

  2017cites this paper
• A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome

  2017cites this paper
• Herbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017

  2017cites this paper
• The metabolism of berberine and its contribution to the pharmacological effects

  2017cites this paper
• Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy.

  2017cites this paper
• Berberine and Its Role in Chronic Disease.

  2016cites this paper
• Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca2+ handling in smooth muscle cells

  2016cites this paper
• Berberine is a potent agonist of peroxisome proliferator activated receptor alpha.

  2016cites this paper